William Rieflin

William Rieflin

DirectoratLyell Immunopharma· In proxies 2023–2025

William Rieflin sits on 8 public boards.

Boards1

  • Lyell ImmunopharmaDirector · 4 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Lyell ImmunopharmaPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -80%
  2. NGM Biopharmaceuticals, Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  3. Kallyope, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Lycia Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Flexus BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  6. RAPT Therapeutics, Inc.Public company · 10 yr
    • Director2015 – 2025 · 10 yrNo stock prices for these years
  7. Anacor Pharmaceuticals, Inc.Public company · 5 yr
    • Director2011 – 2016 · 5 yrNo stock prices for these years
  8. XenoPort, Inc.Public company · 6 yr
    • Director2010 – 2016 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?